COO * Stock Overview
Develops, manufactures, and markets contact lens wearers. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
The Cooper Companies, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1,740.81 |
52 Week High | US$1,627.63 |
52 Week Low | US$1,429.03 |
Beta | 0.94 |
11 Month Change | 6.95% |
3 Month Change | 21.82% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | 27.07% |
Change since IPO | 226.61% |
Recent News & Updates
Recent updates
Shareholder Returns
COO * | MX Medical Equipment | MX Market | |
---|---|---|---|
7D | 9.2% | 0% | 0% |
1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how COO * performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how COO * performed against the MX Market.
Price Volatility
COO * volatility | |
---|---|
COO * Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in MX Market | 0% |
10% least volatile stocks in MX Market | 0% |
Stable Share Price: COO * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine COO *'s volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The Cooper Companies, Inc. Fundamentals Summary
COO * fundamental statistics | |
---|---|
Market cap | Mex$345.64b |
Earnings (TTM) | Mex$4.95b |
Revenue (TTM) | Mex$62.40b |
69.8x
P/E Ratio5.5x
P/S RatioIs COO * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
COO * income statement (TTM) | |
---|---|
Revenue | US$3.67b |
Cost of Revenue | US$1.25b |
Gross Profit | US$2.42b |
Other Expenses | US$2.13b |
Earnings | US$290.80m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.46 |
Gross Margin | 66.03% |
Net Profit Margin | 7.93% |
Debt/Equity Ratio | 36.0% |
How did COO * perform over the long term?
See historical performance and comparison